Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?

Journal of Substance Abuse Treatment

Volumn 27, Issue 3, 2004, Pages 253-263

  Dismuke, Clara E ^a   French, Michael T ^b,e   Salomé, Helena J ^c   Foss, Mark A ^d   Scott, Chris K ^d   Dennis, Michael L ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c NoviLogic Inc   (United States)

^d CHESTNUT HEALTH SYSTEMS   (United States)

^e Department of Biology   (United States)

Author keywords

Addiction treatment; Clinical outcomes; Economic benefits; Economic evaluation

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DATA ANALYSIS; DRUG DEPENDENCE TREATMENT; ECONOMIC EVALUATION; FOLLOW UP; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; INTERVIEW; OUTCOMES RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 14344258529     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2004.08.005     Document Type: Article

References (48)

1. P.G. Barnett, G.S. Zaric, and M.L. Brandeau The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the U.S. Addiction 96 2001 1267 1278
2. J.F. Bishop, and K. Macarounas-Kirchman The pharmacoeconomics of cancer therapies Seminars in Oncology 24 1997 S19-106 S19-111
3. G.M. Chertow Dialysis: Cost-effective "support" for patients with acute renal failure American Journal of Kidney Diseases 31 1998 545 549
4. M.L. Dennis Global Appraisal of Individual Needs (GAIN): Administration guide for the GAIN and related measures (Version 1299) 1999 Chestnut Health Systems Bloomington, IL Available: http://www.chestnut.org/li/gain
5. M.L. Dennis, C.K. Scott, and R. Funk An experimental evaluation of recovery management checkups (RMC) for people with chronic substance abuse disorders Evaluation and Program Planning 26 2003 339 352
6. M.F. Drummond, B.J. O'Brien, G.L. Stoddart, and G.W. Torrance Methods for the economic evaluation of health care programmes 1997 Oxford University Press New York
7. M.T. French Economic evaluation of alcohol treatment services Evaluation and Program Planning 23 2000 27 39
8. M.T. French, K.E. McCollister, J. Cacciola, J. Durell, and R.L. Stephens Benefit-cost analysis of addiction treatment in Arkansas: Specialty and standard residential programs for pregnant and parenting women Substance Abuse 23 2002 31 51
9. M.T. French, K.E. McCollister, S. Sacks, K. McKendrick, and G. De Leon Benefit-cost analysis of a modified therapeutic community for mentally ill chemical abusers Evaluation and Program Planning 25 2002 137 148
10. M.T. French, H.J. Salomé, and M. Carney Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the state of Washington Social Science and Medicine 55 2002 2267 2282
11. M.T. French, H.J. Salomé, A. Krupski, J.R. McKay, D.M. Donovan, A.T. McLellan, and J. Durell Benefit-cost analysis of residential and outpatient addiction treatment in the state of Washington Evaluation Review 24 2000 609 634
12. M.T. French, H.J. Salomé, J.L. Sindelar, and A.T. McLellan Benefit-cost analysis of substance abuse treatment: Methodological guidelines and application using the DATCAP and ASI Health Services Research 37 2002 433 455
13. D.R. Gerstein, R.A. Johnson, H. Harwood, K. Fountain, N. Sutter, and K. Malloy Evaluating recovery services: The California Drug and Alcohol Treatment Assessment (CALDATA), general report 1994 California Department of Alcohol and Drug Program Sacramento, CA
14. M.R. Gold J.E. Siegel L.B. Russell M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York
15. H.J. Harwood, R.L. Hubbard, J. Collins, and J.V. Rachal A cost-benefit analysis of drug abuse treatment Research in Law and Policy Studies 3 1995 191 214
16. J.A. Henry, and C.A. Rivas Constraints on antidepressant prescribing and principles of cost-effective antidepressant use Pharmacoeconomics 11 1997 515 537
17. M. Hollander, and D.A. Wolfe Nonparametric statistical methods 1999 John Wiley & Sons, Inc New York
18. M. Johannesson Theory and methods of economic evaluation of health care 1996 Kluwer Academic Publishers Dordrecht
19. G. Karlsson Economic aspects of chemotherapy Acta Oncologia 40 2001 412 433
20. D. Kenkel On valuing morbidity, cost-effectiveness analysis, and being rude Journal of Health Economics 16 1997 749 757
21. H. Lee, B. Manns, K. Taub, W.A. Ghali, D. Stafford, D. Johnson, and C. Donaldson Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access American Journal of Kidney Diseases 40 2002 611 622
22. K.E. McCollister, M.T. French, J.A. Inciardi, C.A. Butzin, S.S. Martin, and R.M. Hooper Post-release substance abuse treatment for criminal offenders: A cost-effectiveness analysis Journal of Quantitative Criminology 19 2003 389 407
23. K.E. McCollister, M.T. French, M. Prendergast, H. Wexler, S. Sacks, and E. Hall Is in-prison treatment enough? A cost-effectiveness analysis of prison-based treatment and aftercare services for substance-abusing offenders Law and Policy 25 2003 63 82
24. A.T. McLellan, H. Kushner, D. Metzger, R. Peters, I. Smith, G. Grissom, H. Pettinati, and M. Argeriou The fifth edition of the Addiction Severity Index Journal of Substance Abuse Treatment 9 1992 199 213
25. A.T. McLellan, L. Luborsky, G.E. Woody, and C.P. O'Brien An improved diagnostic evaluation instrument for substance abuse patients The Journal of Nervous and Mental Disease 168 1980 26 33
26. Mee-Lee, D., Hoffman, N.G., & Smith, M.B. (1992). RAATE (Recovery Attitude and Treatment Evaluator) Manual (2nd ed.). St. Paul, MN: CATOR/New Standards, Inc.
27. P.E. Mohr The economics of daily dialysis Advances in Renal Replacement Therapy 8 2001 273 279
28. P.J. Panzarino, and D.B. Nash Cost-effective treatment of depression with selective serotonin reuptake inhibitors The American Journal of Managed Care 7 2001 173 184
29. P.D. Peeters, P.M. Rublee, P.M. Just, and A. Joseph Analysis and interpretation of cost data in dialysis: Review of Western European literature Health Policy 54 2000 209 227
30. R.D. Plotnick Applying benefit-cost analysis to substance use prevention programs International Journal of Addiction 29 1994 339 359
31. A.S. Rajkumar, and M.T. French Drug abuse, crime costs, and the economic benefits of treatment Journal of Quantitative Criminology 13 1997 291 323
32. B. Rouse N. Kozel L. Richards Self-report methods of estimating drug use: Meeting current challenges to validity 1985 National Institute on Drug Abuse Rockville, MD
33. D.B. Rubin Multiple imputation for non-response in surveys 1987 John Wiley & Sons New York
34. H.J. Salomé, M.T. French, M. Miller, and A.T. McLellan Estimating the client costs of addiction treatment: First findings from the Client DATCAP Drug and Alcohol Dependence 71 2003 195 206
35. H.J. Salomé, M.T. French, C. Scott, M. Foss, and M. Dennis Investigating variation in the costs and benefits of addiction treatment: Econometric analysis of the Chicago Target Cities Project Evaluation and Program Planning 26 2003 325 338
36. D. Sclar, L. Robinson, T.L. Skaer, R.F. Legg, N.L. Nemec, R.S. Galin, T.E. Hughes, and D.P. Buesching Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization Current Therapeutic Research: Clinical and Experimental 55 1994 1056 1066
37. C.K. Scott, M.A. Foss, and M.L. Dennis Factors influencing initial and longer- term responses to substance abuse treatment: A path analysis Evaluation and Program Planning 26 2003 287 295
38. C.K. Scott, M.A. Foss, M.L. Dennis, and M.D. Godley Target Chicago: Summary of evaluation design and methodology 2000 Chestnut Health Systems Chicago
39. C.K. Scott, M.A. Foss, and R.E. Sherman Effects of centralized intake on participant satisfaction with treatment and ancillary services R.C. Stephens C.K. Scott R.D. Muck Changing the treatment delivery system: Findings from the Target Cities Demonstration Program 2003 State University of New York Press Albany, NY 149 164
40. C.K. Scott, and R.D. Muck Background and overview of the Target Cities Demonstration Program R.C. Stephens C.K. Scott R.D. Muck Changing the treatment delivery system: Findings from the Target Cities Demonstration Program 2003 State University of New York Press Albany, NY 1 16
41. C.K. Scott, R.D. Muck, and M.A. Foss The impact of centralized intake on access to treatment and satisfaction with intake procedures J.A. Levy R.C. Stephens D.C. McBride Advances in medical sociology: Vol. 7, Emergent issues in the field of drug abuse 2000 JAI Press Stamford, CT 131 150
42. F.A. Sloan Valuing health care 1996 Cambridge University Press New York
43. StataCorp Stata Statistical Software: Release 7.0 2001 Stata Corporation College Station, TX
44. V. Tabbush The effectiveness and efficiency of publicly funded drug abuse treatment and prevention programs in California: A benefit-cost analysis 1986 University of California Press
45. G. Tolley D. Kenkel R. Fabian Valuing health for policy: An economic approach 1994 The University of Chicago Press Chicago
46. J.W. Tukey The future of data analysis Annals of Mathematical Statistics 33 1962 1 67
47. C. Turner, J. Lessler, and J. Devore Effects of mode of administration and wording on reporting of drug use Survey measurement of drug use: Methodological studies 1992 National Institute on Drug Abuse Rockville, MD
48. G.A. Zarkin, R.C. Lindrooth, B. Demiralp, and W. Wechsberg The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV Health Services Research 36 2001 335 356